从救援到康复:通过90天生存率重新定义严重酒精性肝炎的管理
1Department of Internal Medicine, Suez University, Suez 43511, Egypt. amira.othman@med.suezuni.edu.eg.
World journal of gastroenterology
|December 8, 2025
概括
严重酒精性肝炎的治疗正在将重点转移到90天生存期. 像便微生物种移植 (FMT) 和颗粒细胞殖民地刺激因子 (G-CSF) 这样的有希望的疗法显示出超出短期皮质类固醇益处的潜力.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 内部医学 内部医学
背景情况:
- 严重的酒精性肝炎带来紧急的临床挑战,并导致高早期死亡率.
- 皮质类固醇提供有限的长期益处,在第一个月后出现感染和复发等关键威胁.
研究的目的:
- 为了将专注于严重酒精性肝炎的90天存活率的系统审查置于背景中.
- 评估超越传统短期终点的新兴干预措施.
主要方法:
- 对严重酒精性肝炎治疗方法的最近临床研究进行系统审查和综合.
- 干预措施的分析,包括便微生物种移植 (FMT),花细胞殖民地刺激因子 (G-CSF),血交换和向生物制剂.
主要成果:
- 便微生物群移植 (FMT) 在一项随机试验中改善了90天的生存率.
- 颗粒细胞殖民地刺激因子 (G-CSF) 在大量回顾性队列中显示出生存益处.
- 新兴的策略显示出解决晚期并发症的前景.
结论:
- 建议采用两阶段的护理模式 (稳定,然后巩固).
- 在等待进一步试验的情况下,FMT和G-CSF是对皮质类固醇不响应患者的潜在选择.
- 采用90天生存率作为指标,可以更现实地评估治疗成功率.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
291
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
291
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
203
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
203
Esophageal Varices-II: Clinical Features and Management
343
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
343
Acute Pancreatitis II: Clinical Manifestations and Management
705
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
705
Myocarditis IV: Nursing Management
196
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
196


